Search research articles
Contact Us
Filters
Showing results (151-160 of 308) with videos related to
Page
of 31
Sort By:
Cancer
|
February 13, 2025
Maintenance therapy with the FMS-like tyrosine kinase 3 inhibitor gilteritinib in patients with FMS-like tyrosine kinase 3-internal tandem duplication acute myeloid leukemia: A phase 2 study
Emmanuel Gyan, Mark D Minden, Kohmei Kubo, et al.
Biorxiv : the Preprint Server for Biology
|
June 29, 2026
Multi-platform reassessment of human mitochondrial DNA methylation reveals signals consistent with technical artifacts
Salman Basrai, Alexander T Bahcheli, Djarren Tan, et al.
Molecular Cancer Therapeutics
|
November 13, 2008
A novel inhibitor of glucose uptake sensitizes cells to FAS-induced cell death
Tabitha E Wood, Shadi Dalili, Craig D Simpson, et al.
Cell Death & Disease
|
December 23, 2016
Phosphorylated STAT5 regulates p53 expression via BRCA1/BARD1-NPM1 and MDM2
Zhuo Ren, Joeri L Aerts, Hugo Vandenplas, et al.
Leukemia Research
|
August 22, 2016
A phase I trial of the human double minute 2 inhibitor (MK-8242) in patients with refractory/recurrent acute myelogenous leukemia (AML)
Farhad Ravandi, Ivana Gojo, Mrinal M Patnaik, et al.
Nature Communications
|
April 29, 2021
Recurrent deletions in clonal hematopoiesis are driven by microhomology-mediated end joining
Tzah Feldman, Akhiad Bercovich, Yoni Moskovitz, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 31, 2025
Identifying Risk Factors and Outcome for CNS Involvement in AML
Jack T Seki, Georgina S Daher-Reyes, Eshetu G Atenafu, et al.
American Journal of Hematology
|
December 1, 2015
Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: 10-Color flow cytometry diagnosis and HyperCVAD therapy
Uday Deotare, Karen W L Yee, Lisa W Le, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 20, 2020
Combined loss of function of two different loci of miR-15/16 drives the pathogenesis of acute myeloid leukemia
Francesca Lovat, Giovanni Nigita, Rosario Distefano, et al.
Experimental Hematology
|
October 24, 2018
Characterization of inv(3) cell line OCI-AML-20 with stroma-dependent CD34 expression
Genna M Luciani, Lihua Xie, David Dilworth, et al.
Page
of 31
Search research articles
Search
Showing results (151-160 of 308) with videos related to
Sort By:
Page
of 31
Cancer
|
February 13, 2025
Maintenance therapy with the FMS-like tyrosine kinase 3 inhibitor gilteritinib in patients with FMS-like tyrosine kinase 3-internal tandem duplication acute myeloid leukemia: A phase 2 study
Emmanuel Gyan, Mark D Minden, Kohmei Kubo, et al.
Biorxiv : the Preprint Server for Biology
|
June 29, 2026
Multi-platform reassessment of human mitochondrial DNA methylation reveals signals consistent with technical artifacts
Salman Basrai, Alexander T Bahcheli, Djarren Tan, et al.
Molecular Cancer Therapeutics
|
November 13, 2008
A novel inhibitor of glucose uptake sensitizes cells to FAS-induced cell death
Tabitha E Wood, Shadi Dalili, Craig D Simpson, et al.
Cell Death & Disease
|
December 23, 2016
Phosphorylated STAT5 regulates p53 expression via BRCA1/BARD1-NPM1 and MDM2
Zhuo Ren, Joeri L Aerts, Hugo Vandenplas, et al.
Leukemia Research
|
August 22, 2016
A phase I trial of the human double minute 2 inhibitor (MK-8242) in patients with refractory/recurrent acute myelogenous leukemia (AML)
Farhad Ravandi, Ivana Gojo, Mrinal M Patnaik, et al.
Nature Communications
|
April 29, 2021
Recurrent deletions in clonal hematopoiesis are driven by microhomology-mediated end joining
Tzah Feldman, Akhiad Bercovich, Yoni Moskovitz, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 31, 2025
Identifying Risk Factors and Outcome for CNS Involvement in AML
Jack T Seki, Georgina S Daher-Reyes, Eshetu G Atenafu, et al.
American Journal of Hematology
|
December 1, 2015
Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: 10-Color flow cytometry diagnosis and HyperCVAD therapy
Uday Deotare, Karen W L Yee, Lisa W Le, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 20, 2020
Combined loss of function of two different loci of miR-15/16 drives the pathogenesis of acute myeloid leukemia
Francesca Lovat, Giovanni Nigita, Rosario Distefano, et al.
Experimental Hematology
|
October 24, 2018
Characterization of inv(3) cell line OCI-AML-20 with stroma-dependent CD34 expression
Genna M Luciani, Lihua Xie, David Dilworth, et al.
Page
of 31